CoChat
Sign Up
Cited by 15

The DOI matches its Crossref record.

ApoD Mediates Binding of HDL to LDL and to Growing T24 Carcinoma

Braesch-Andersen, Sten, Beckman, Lena, Paulie, Staffan, Kumagai-Braesch, Makiko·2014·PLoS ONE
DOI 10.1371/journal.pone.0115180PMC PMC4267786
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0115180

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Apolipoprotein D is primarily produced in the brain and mediates interaction between HDL and LDL in plasma.

    “Apolipoprotein D is an apolipoprotein primarily produced in the brain and is associated with mediating the interaction between HDL and LDL in the plasma (60, 61).”

    From Lipidome and proteome of astrocyte and microglia ApoE lipoprotein reveal differences based on cell type and ApoE isoform (2026) · cites this paper as [60]

    The Abstract and Discussion support ApoD’s role in HDL–LDL binding in human plasma, though the Discussion presents its physiological mediator role as a proposal. The Introduction says ApoD is expressed throughout the body, notably by brain glial cells and fibroblasts; it does not establish that ApoD is primarily produced in the brain. Page numbers are not provided in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 36

  1. G Bittilo Bon, 1981, Preparative isotachophoresis of human plasma high density lipoproteins HDL2 and HDL3, J Lipid Res, 22, 998, 10.1016/S0022-2275(20)37337-5 · DOI
  2. E Rassart, 2000, Apolipoprotein D, Biochim Biophys Acta, 1482, 185, 10.1016/S0167-4838(00)00162-X · DOI · Paper page
  3. G Perdomo, 2009, Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging, Aging (Albany NY), 1, 17, 10.18632/aging.100004 · DOI
  4. M Balbin, 1990, Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease, Biochem J, 271, 803, 10.1042/bj2710803 · DOI
  5. J Muffat, 2008, Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila, Proc Natl Acad Sci U S A, 105, 7088, 10.1073/pnas.0800896105 · DOI
  6. MD Ganfornina, 2008, Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress, Aging Cell, 7, 506, 10.1111/j.1474-9726.2008.00395.x · DOI
  7. JK Boyles, 1990, Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A–I, J Biol Chem, 265, 17805, 10.1016/S0021-9258(18)38235-8 · DOI
  8. MD Ganfornina, 2010, ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury, Glia, 58, 1320, 10.1002/glia.21010 · DOI
  9. P Spreyer, 1990, Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve, EMBO J, 9, 2479, 10.1002/j.1460-2075.1990.tb07426.x · DOI
  10. J Muffat, 2010, Apolipoprotein D: an overview of its role in aging and age-related diseases, Cell Cycle, 9, 269, 10.4161/cc.9.2.10433 · DOI
  11. S Dassati, 2014, Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain, Neurobiol Aging, 35, 1632, 10.1016/j.neurobiolaging.2014.01.148 · DOI · Paper page
  12. K Tsukamoto, 2013, Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease, Proc Natl Acad Sci U S A, 110, 17023, 10.1073/pnas.1315986110 · DOI
  13. S Do Carmo, 2008, Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice, J Neurosci, 28, 10330, 10.1523/JNEUROSCI.2644-08.2008 · DOI
  14. DA Elliott, 2010, Apolipoproteins in the brain: implications for neurological and psychiatric disorders, Clin Lipidol, 51, 555, 10.2217/clp.10.37 · DOI · Paper page
  15. PP Desai, 2003, Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans, Am J Med Genet B Neuropsychiatr Genet, 116B, 98, 10.1002/ajmg.b.10798 · DOI
  16. S Helisalmi, 2004, Genetic variation in apolipoprotein D and Alzheimer's disease, J Neurol, 251, 951, 10.1007/s00415-004-0470-8 · DOI
  17. Y Chen, 2008, Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease, Brain Res, 1233, 196, 10.1016/j.brainres.2008.07.018 · DOI
  18. G Perdomo, 2010, A role of apolipoprotein D in triglyceride metabolism, J Lipid Res, 51, 1298, 10.1194/jlr.M001206 · DOI
  19. M Jimenez-Palomares, 2011, Genetic deficiency of apolipoprotein D in the mouse is associated with nonfasting hypertriglyceridemia and hyperinsulinemia, Metabolism, 60, 1767, 10.1016/j.metabol.2011.04.013 · DOI
  20. L Holmquist, 1989, Separation of free and apolipoprotein D-associated human plasma lecithin: cholesterol acyltransferase, J Biochem Biophys Methods, 19, 93, 10.1016/0165-022X(89)90054-7 · DOI
  21. E Steyrer, 1988, Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: comparison of proteoliposomes containing apolipoprotein D, A–I or C–I, Biochim Biophys Acta, 958, 484, 10.1016/0005-2760(88)90235-4 · DOI
  22. PE Fielding, 1980, A cholesteryl ester transfer complex in human plasma, Proc Natl Acad Sci U S A, 77, 3327, 10.1073/pnas.77.6.3327 · DOI
  23. S Bhatia, 2012, Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease, Biochem J, 442, 713, 10.1042/BJ20111166 · DOI
  24. PR Provost, 1991, Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures, FEBS Lett, 290, 139, 10.1016/0014-5793(91)81244-3 · DOI
  25. K Sugimoto, 1994, Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells, J Steroid Biochem Mol Biol, 51, 167, 10.1016/0960-0760(94)90090-6 · DOI
  26. YS Lopez-Boado, 1997, Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression, Cancer Res, 57, 4091
  27. S Do Carmo, 2002, Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter, J Biol Chem, 277, 5514, 10.1074/jbc.M105057200 · DOI
  28. JM Sarjeant, 2003, Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus, Arterioscler Thromb Vasc Biol, 23, 2172, 10.1161/01.ATV.0000100404.05459.39 · DOI
  29. R Bajo-Graneras, 2013, Expression and potential role of apolipoprotein D on the death-survival balance of human colorectal cancer cells under oxidative stress conditions, Int J Colorectal Dis, 28, 751, 10.1007/s00384-012-1616-2 · DOI
  30. NE Miller, 1977, Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts, J Clin Invest, 60, 78, 10.1172/JCI108772 · DOI
  31. C Bancells, 2010, Proteomic analysis of electronegative low-density lipoprotein, J Lipid Res, 51, 3508, 10.1194/jlr.M009258 · DOI
  32. HV de Silva, 1990, A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins, J Biol Chem, 265, 13240, 10.1016/S0021-9258(19)38290-0 · DOI
  33. H Mehdi, 1999, Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations, Hum Genet, 105, 63
  34. M Yoshikawa, 1997, HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2, Clin Biochem, 30, 221, 10.1016/S0009-9120(97)00031-3 · DOI
  35. B Shao, 2009, HDL, lipid peroxidation, and atherosclerosis, J Lipid Res, 50, 599, 10.1194/jlr.E900001-JLR200 · DOI
  36. JH Kim, 2011, Matrix stiffening sensitizes epithelial cells to EGF and enables the loss of contact inhibition of proliferation, J Cell Sci, 124, 1280, 10.1242/jcs.078394 · DOI

Cited by

Sorted by citations

Metadata

Authors
Braesch-Andersen, S., Beckman, L., Paulie, S., & Kumagai-Braesch, M.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2014-12-16
Volume
9
Issue
12
Pages
e115180
ISSN
1932-6203
DOI
10.1371/journal.pone.0115180
PMC
PMC4267786
Cited by
15
References
0
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review